Administrators, Administrators, translator
10
edits
Riccardo Polosa: Difference between revisions
Jump to navigation
Jump to search
m
added a link to the internal page for LIAF
(added internal link for liaf) |
m (added a link to the internal page for LIAF) |
||
| Line 2: | Line 2: | ||
[https://en.wikipedia.org/wiki/Riccardo_Polosa Wikipedia Entry] | [https://en.wikipedia.org/wiki/Riccardo_Polosa Wikipedia Entry] | ||
'''Riccardo Polosa''' is an Italian academic, who in 2018 described his roles as "Full Professor of Internal Medicine and specialist of Respiratory Diseases and Clinical Immunology at the University of Catania as well as the Founder and Clinical Director of the Center for Tobacco Research and Scientific Director of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR) at the same University."<ref>[http://blogs.biomedcentral.com/on-health/2018/05/31/world-no-tobacco-day-mathieu-morissette-riccardo-polosa/ "World No Tobacco Day: Q&A with Mathieu Morissette and Riccardo Polosa"], 31 May 2018</ref> | '''Riccardo Polosa''' is an Italian academic, who in 2018 described his roles as "Full Professor of Internal Medicine and specialist of Respiratory Diseases and Clinical Immunology at the University of Catania as well as the Founder and Clinical Director of the Center for Tobacco Research and Scientific Director of the Center of Excellence for the acceleration of HArm Reduction (CoEHAR) at the same University."<ref>[http://blogs.biomedcentral.com/on-health/2018/05/31/world-no-tobacco-day-mathieu-morissette-riccardo-polosa/ "World No Tobacco Day: Q&A with Mathieu Morissette and Riccardo Polosa"], 31 May 2018</ref> | ||
| Line 11: | Line 9: | ||
He is actively involved in smoking prevention and cessation. Indeed, he established the first Sicilian center for smoking cessation at the University of Catania in 2002. | He is actively involved in smoking prevention and cessation. Indeed, he established the first Sicilian center for smoking cessation at the University of Catania in 2002. | ||
In 2003, he founded the | In 2003, he founded the Italian Antismoking Association ([[LIAF]]), which he directed for 5 years. | ||
In 2018, Polosa established, together with 38 academics, the [[Center of Excellence for the acceleration of HArm Reduction]] ([https://www.coehar.org CoEHAR]) at the University of Catania, a unique multi-disciplinary research centre with the mission to reduce health impacts and deaths from smoking, locally and globally. | In 2018, Polosa established, together with 38 academics, the [[Center of Excellence for the acceleration of HArm Reduction]] ([https://www.coehar.org CoEHAR]) at the University of Catania, a unique multi-disciplinary research centre with the mission to reduce health impacts and deaths from smoking, locally and globally. | ||
In the area of in tobacco control and prevention, he has been the most prolific author in the field of electronic cigarettes – according to a paper published in BMC Public Health.<ref>{{Cite web|title=Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis|url=https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-667|url-status=live}}</ref> He is the lead author of ECLAT- first randomized controlled trial <ref>{{Cite web|title=EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317|url-status=live}}</ref> in the world about effectiveness and tolerability of e-cigarettes. | In the area of in tobacco control and prevention, he has been the most prolific author in the field of electronic cigarettes – according to a paper published in BMC Public Health.<ref>{{Cite web|title=Worldwide research productivity in the field of electronic cigarette: a bibliometric analysis|url=https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-14-667|url-status=live}}</ref> He is the lead author of ECLAT- first randomized controlled trial <ref>{{Cite web|title=EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as Tobacco Cigarettes Substitute: A Prospective 12-Month Randomized Control Design Study|url=https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066317|url-status=live}}</ref> in the world about effectiveness and tolerability of e-cigarettes. | ||